Nephros Inc. (NEPH) NASDAQ

$2.06 (0.07) (-3.29%)

Market Cap: $22.46M

As of 05/15/24 03:59 PM EDT. Market closed.

(NEPH)

Nephros Inc. (NEPH)
NASDAQ

$2.06
(0.07) (-3.29%)

Market Cap: $22.46M

As of 05/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to ... read more

COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
Full Time Employees
56
Address
.
PRICE CHART FOR NEPHROS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.18
Previous Close
$2.13
Days Range
$2.05 - $2.14
52 week range
$1.13 - $4.04
Volume
5,789
Avg. Volume (30 days)
12,811
Market Cap
$22.46M
Dividend Yield
-
P/E
-
Shares Outstanding
10,544,139
Open
$2.18
Previous Close
$2.13
Days Range
$2.05 - $2.14
52 week range
$1.13 - $4.04
Volume
5,789
Avg. Volume (30 days)
12,811
Market Cap
$22.46M
Dividend Yield
-
P/E
-
Shares Outstanding
10,544,139
FINANCIAL STATEMENTS FOR NEPHROS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR NEPHROS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Amron Arthur HDirectorMar 12, 2024 Buy$2.457,00017,1307,000Mar 14, 2024, 04:28 PM
Banks Robert R. Jr.President and CEODec 07, 2023 Buy$2.2018,00039,64720,000Dec 11, 2023, 04:17 PM
Banks Robert R. Jr.President and CEOAug 15, 2023 Buy$1.691,9013,2072,000Aug 15, 2023, 04:15 PM
Banks Robert R. Jr.President and CEOAug 14, 2023 Buy$1.509914999Aug 15, 2023, 04:15 PM
Astor AndrewPresident, CEO & CFOMar 05, 2022 Option Exercise$2.7014,81540,00192,773Mar 07, 2022, 05:44 PM
Lobo Wesley S.Chief Marketing OfficerFeb 16, 2022 Option Exercise$4.806,38930,66735,168Feb 18, 2022, 05:03 PM
Lobo Wesley S.Chief Marketing OfficerAug 20, 2021 Buy$7.921,0007,92041,557Aug 23, 2021, 01:01 PM
Gwydir TomDirectorAug 18, 2021 Buy$7.645,00038,20011,031Aug 19, 2021, 09:04 PM
Astor AndrewPresident & CEOAug 17, 2021 Buy$7.672,50019,17275,458Aug 18, 2021, 06:08 PM
Astor AndrewPresident & CEOAug 18, 2021 Buy$7.772,50019,43377,958Aug 18, 2021, 06:08 PM
Evans DaronCEO Specialty Renal ProductsMay 27, 2021 Option Exercise$2.703499428,669Jun 01, 2021, 05:39 PM
Evans DaronCEO Specialty Renal ProductsMay 27, 2021 Option Exercise$2.703499428,947Jun 01, 2021, 05:39 PM
Evans DaronCEO of Specialty Renal ProductMay 24, 2021 Option Exercise$2.701,1113,0009,018May 25, 2021, 03:40 PM
Evans DaronCEO of Specialty Renal ProductMay 24, 2021 Option Exercise$2.701,1113,0009,296May 25, 2021, 03:40 PM
WEXFORD CAPITAL LPDirectorJan 27, 2021 Option Exercise$4.2214,75462,260106,037Jan 29, 2021, 04:49 PM
Spandow Oliver J.DirectorNov 18, 2020 Buy$5.831,5008,74915,734Nov 20, 2020, 04:28 PM
Astor AndrewPresident & CEONov 19, 2020 Buy$5.871,0005,86772,958Nov 19, 2020, 06:17 PM
WEXFORD CAPITAL LPDirectorOct 15, 2020 Option Exercise$6.00166,6671,000,0023,605,471Oct 16, 2020, 04:38 PM
Astor AndrewCOO/CFOAug 19, 2020 Buy$7.409507,03071,958Aug 19, 2020, 06:22 PM
Astor AndrewCFO/COOMay 28, 2020 Buy$6.961,0006,96071,008May 29, 2020, 06:08 PM
PERSEN MALCOLM CDirectorMay 11, 2020 Option Exercise$7.651,73213,2505,194May 13, 2020, 04:56 PM
Evans DaronPresident and CEOMar 12, 2020 Buy$6.652,50016,625134,215Mar 12, 2020, 05:02 PM
Astor AndrewCFO/COOMar 12, 2020 Buy$6.701,0006,70070,008Mar 12, 2020, 04:50 PM
Evans DaronPresident and CEOMar 05, 2020 Buy$8.442,50021,109131,715Mar 05, 2020, 05:18 PM
Astor AndrewCFO/COOMar 05, 2020 Buy$8.467005,92069,008Mar 05, 2020, 05:10 PM
Spandow Oliver J.DirectorNov 25, 2019 Buy$8.171,0008,17010,786Nov 26, 2019, 04:25 PM
Astor AndrewCFO/COONov 18, 2019 Buy$8.387506,28261,460Nov 18, 2019, 12:13 PM
Evans DaronPresident and CEONov 18, 2019 Buy$8.351,0008,350119,933Nov 18, 2019, 12:12 PM
Lask AlisaDirectorSep 11, 2019 Buy$6.452501,612250Sep 13, 2019, 04:32 PM
Astor AndrewCFO/COOAug 22, 2019 Buy$6.971,50010,45560,710Aug 22, 2019, 04:37 PM
Evans DaronPresident and CEOAug 22, 2019 Buy$6.922,00013,845118,933Aug 22, 2019, 04:09 PM
Astor AndrewCFO/COOJun 14, 2019 Buy$0.6435,00022,400532,903Jun 14, 2019, 12:35 PM
Evans DaronPresident and CEOJun 14, 2019 Buy$0.598,0004,72071,166Jun 14, 2019, 12:34 PM
Evans DaronPresident and CEOJun 14, 2019 Buy$0.588,0004,65373,666Jun 14, 2019, 12:34 PM
Evans DaronPresident and CEOJun 14, 2019 Buy$0.6011,1726,6831,052,426Jun 14, 2019, 12:34 PM
Evans DaronPresident and CEOJun 14, 2019 Buy$0.608,0004,8308,000Jun 14, 2019, 12:34 PM
Evans DaronPresident and CEOJun 14, 2019 Buy$0.618,0004,8758,000Jun 14, 2019, 12:34 PM
Astor AndrewChief Financial OfficerMay 14, 2018 Option Exercise$0.3033,33310,000453,792May 14, 2018, 04:44 PM
Evans DaronPresident and CEOMay 14, 2018 Option Exercise$0.3040,00012,00095,000May 14, 2018, 07:27 AM
Evans DaronPresident and CEOApr 10, 2018 Buy$0.4512,0005,40065,666Apr 12, 2018, 04:12 PM
Evans DaronPresident and CEOApr 10, 2018 Buy$0.4555,00024,75055,000Apr 12, 2018, 04:12 PM
Evans DaronPresident and CEOApr 10, 2018 Buy$0.4512,0005,40063,166Apr 12, 2018, 04:12 PM
Astor AndrewChief Financial OfficerApr 10, 2018 Buy$0.4580,00036,000420,459Apr 12, 2018, 04:11 PM
Astor AndrewChief Financial OfficerMar 09, 2018 Buy$0.475,0002,375340,459Mar 13, 2018, 04:08 PM
Astor AndrewChief Financial OfficerDec 04, 2017 Buy$0.508,3334,167215,042Dec 05, 2017, 04:17 PM
Astor AndrewChief Financial OfficerDec 01, 2017 Buy$0.5010,0005,000206,709Dec 05, 2017, 04:17 PM
Evans DaronPresident and CEOSep 06, 2017 Buy$0.2428,0006,818712,958Sep 06, 2017, 05:13 PM
Evans DaronPresident and CEOSep 05, 2017 Buy$0.231,580371684,958Sep 06, 2017, 05:13 PM
Astor AndrewChief Financial OfficerJun 16, 2017 Option Exercise$0.264311186,709Aug 28, 2017, 04:53 PM
Astor AndrewChief Financial OfficerAug 28, 2017 Buy$0.2710,0002,712196,709Aug 28, 2017, 04:53 PM
Evans DaronPresident and CEOAug 22, 2017 Buy$0.252,00050051,166Aug 23, 2017, 12:51 PM
Evans DaronPresident and CEOAug 22, 2017 Buy$0.252,00050053,666Aug 23, 2017, 12:51 PM
Evans DaronPresident and CEOAug 11, 2017 Buy$0.2670,00018,200683,378Aug 11, 2017, 05:35 PM
Astor AndrewChief Financial OfficerAug 11, 2017 Buy$0.2620,0005,198186,666Aug 11, 2017, 05:35 PM
Evans DaronPresident and CEOJun 09, 2017 Buy$0.267,5001,95049,166Jun 13, 2017, 04:19 PM
Evans DaronPresident and CEOJun 09, 2017 Buy$0.2610,0002,60051,666Jun 13, 2017, 04:19 PM
Evans DaronPresident and CEOJun 12, 2017 Buy$0.263,9611,030613,378Jun 13, 2017, 04:19 PM
Evans DaronPresident and CEOMay 19, 2017 Buy$0.257,5001,912609,417May 19, 2017, 05:55 PM
Evans DaronPresident and CEOMay 18, 2017 Buy$0.2522,5005,737601,917May 19, 2017, 05:55 PM
Evans DaronPresident and CEODec 07, 2016 Buy$0.324,0691,302339,428Dec 09, 2016, 05:11 PM
Evans DaronPresident and CEODec 05, 2016 Buy$0.3410,6203,610335,359Dec 06, 2016, 04:37 PM
Evans DaronPresident and CEODec 01, 2016 Buy$0.3240,59913,016324,739Dec 02, 2016, 04:28 PM
Evans DaronPresident and CEONov 30, 2016 Buy$0.29931270284,140Dec 02, 2016, 04:28 PM
Evans DaronPresident and CEOAug 27, 2015 Buy$0.5619,17510,738144,759Aug 31, 2015, 04:24 PM
Evans DaronPresident and CEOAug 31, 2015 Buy$0.5710,0005,700169,759Aug 31, 2015, 04:24 PM
Evans DaronPresident and CEOAug 28, 2015 Buy$0.5915,0008,900159,759Aug 31, 2015, 04:24 PM
Evans DaronPresident and CEOAug 20, 2015 Buy$0.5627,00015,120125,584Aug 20, 2015, 06:43 PM
Evans DaronPresident and CEOAug 19, 2015 Buy$0.5024,50012,25098,584Aug 20, 2015, 06:43 PM
CENTELLA LAWRENCE JDirectorDec 18, 2014 Option Exercise$0.6010,2026,121121,332Dec 22, 2014, 06:39 PM
ROSENBERG MATTHEWDirectorDec 18, 2014 Option Exercise$0.60374,997224,998589,695Dec 22, 2014, 05:57 PM
Houghton John C.President, CEO and Acting CFODec 18, 2014 Option Exercise$0.607,8854,73174,139Dec 22, 2014, 05:56 PM
Evans DaronDirectorDec 18, 2014 Option Exercise$0.6021,23912,74374,084Dec 22, 2014, 05:53 PM
Evans DaronDirectorMar 21, 2014 Option Exercise$0.302,1516459,651Mar 27, 2014, 04:45 PM
CENTELLA LAWRENCE JDirectorMar 21, 2014 Option Exercise$0.3019,1055,73285,735Mar 24, 2014, 05:22 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Amron Arthur HDirector03/12/202417,130
Banks Robert R. Jr.President and CEO12/07/202339,647
Banks Robert R. Jr.President and CEO08/15/20233,207
Banks Robert R. Jr.President and CEO08/14/2023149
Astor AndrewPresident, CEO & CFO03/05/202240,001
Lobo Wesley S.Chief Marketing Officer02/16/202230,667
Lobo Wesley S.Chief Marketing Officer08/20/20217,920
Gwydir TomDirector08/18/202138,200
Astor AndrewPresident & CEO08/17/202119,172
Astor AndrewPresident & CEO08/18/202119,433
Evans DaronCEO Specialty Renal Products05/27/2021942
Evans DaronCEO Specialty Renal Products05/27/2021942
Evans DaronCEO of Specialty Renal Product05/24/20213,000
Evans DaronCEO of Specialty Renal Product05/24/20213,000
WEXFORD CAPITAL LPDirector01/27/202162,260
Spandow Oliver J.Director11/18/20208,749
Astor AndrewPresident & CEO11/19/20205,867
WEXFORD CAPITAL LPDirector10/15/20201,000,002
Astor AndrewCOO/CFO08/19/20207,030
Astor AndrewCFO/COO05/28/20206,960
PERSEN MALCOLM CDirector05/11/202013,250
Evans DaronPresident and CEO03/12/202016,625
Astor AndrewCFO/COO03/12/20206,700
Evans DaronPresident and CEO03/05/202021,109
Astor AndrewCFO/COO03/05/20205,920
Spandow Oliver J.Director11/25/20198,170
Astor AndrewCFO/COO11/18/20196,282
Evans DaronPresident and CEO11/18/20198,350
Lask AlisaDirector09/11/20191,612
Astor AndrewCFO/COO08/22/201910,455
Evans DaronPresident and CEO08/22/201913,845
Astor AndrewCFO/COO06/14/201922,400
Evans DaronPresident and CEO06/14/20194,720
Evans DaronPresident and CEO06/14/20194,653
Evans DaronPresident and CEO06/14/20196,683
Evans DaronPresident and CEO06/14/20194,830
Evans DaronPresident and CEO06/14/20194,875
Astor AndrewChief Financial Officer05/14/201810,000
Evans DaronPresident and CEO05/14/201812,000
Evans DaronPresident and CEO04/10/20185,400
Evans DaronPresident and CEO04/10/201824,750
Evans DaronPresident and CEO04/10/20185,400
Astor AndrewChief Financial Officer04/10/201836,000
Astor AndrewChief Financial Officer03/09/20182,375
Astor AndrewChief Financial Officer12/04/20174,167
Astor AndrewChief Financial Officer12/01/20175,000
Evans DaronPresident and CEO09/06/20176,818
Evans DaronPresident and CEO09/05/2017371
Astor AndrewChief Financial Officer06/16/201711
Astor AndrewChief Financial Officer08/28/20172,712
Evans DaronPresident and CEO08/22/2017500
Evans DaronPresident and CEO08/22/2017500
Evans DaronPresident and CEO08/11/201718,200
Astor AndrewChief Financial Officer08/11/20175,198
Evans DaronPresident and CEO06/09/20171,950
Evans DaronPresident and CEO06/09/20172,600
Evans DaronPresident and CEO06/12/20171,030
Evans DaronPresident and CEO05/19/20171,912
Evans DaronPresident and CEO05/18/20175,737
Evans DaronPresident and CEO12/07/20161,302
Evans DaronPresident and CEO12/05/20163,610
Evans DaronPresident and CEO12/01/201613,016
Evans DaronPresident and CEO11/30/2016270
Evans DaronPresident and CEO08/27/201510,738
Evans DaronPresident and CEO08/31/20155,700
Evans DaronPresident and CEO08/28/20158,900
Evans DaronPresident and CEO08/20/201515,120
Evans DaronPresident and CEO08/19/201512,250
CENTELLA LAWRENCE JDirector12/18/20146,121
ROSENBERG MATTHEWDirector12/18/2014224,998
Houghton John C.President, CEO and Acting CFO12/18/20144,731
Evans DaronDirector12/18/201412,743
Evans DaronDirector03/21/2014645
CENTELLA LAWRENCE JDirector03/21/20145,732
Load More Insider Transactions
FUNDS WITH A POSITION IN NEPHROS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC71,0370.00001%No changeOther
RENAISSANCE TECHNOLOGIES LLC41,2000.00014%NewOther
BLACKROCK INC.4,1310%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR NEPHROS INC
STOCK BUYBACKS FOR NEPHROS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.26%
1Q
12/31/2023
06/30/2023
1.85%
2Q
12/31/2023
03/31/2023
1.85%
3Q
12/31/2023
12/31/2022
1.29%
4Q
12/31/2023
09/30/2022
1.79%
5Q
12/31/2023
06/30/2022
1.83%
6Q
12/31/2023
03/31/2022
2.68%
7Q
12/31/2023
12/31/2021
2.83%
8Q
12/31/2023
09/30/2021
4.41%
9Q
12/31/2023
06/30/2021
5.48%
10Q
12/31/2023
03/31/2021
6.12%
11Q
12/31/2023
12/31/2020
8.16%
12Q
12/31/2023
09/30/2020
16.02%
13Q
12/31/2023
06/30/2020
16.71%
14Q
12/31/2023
03/31/2020
22.09%
15Q
12/31/2023
12/31/2019
32.03%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.26%
1Q
06/30/2023
1.85%
2Q
03/31/2023
1.85%
3Q
12/31/2022
1.29%
4Q
09/30/2022
1.79%
5Q
06/30/2022
1.83%
6Q
03/31/2022
2.68%
7Q
12/31/2021
2.83%
8Q
09/30/2021
4.41%
9Q
06/30/2021
5.48%
10Q
03/31/2021
6.12%
11Q
12/31/2020
8.16%
12Q
09/30/2020
16.02%
13Q
06/30/2020
16.71%
14Q
03/31/2020
22.09%
15Q
12/31/2019
32.03%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NEPHROS INC
LOADING...